• NEWS
    • Australian Shares
    • US Shares
    • World Economy
  • ASX Companies
    • Consumer
    • Energy
    • Financial
    • Food & Beverages
    • Healthcare
    • Industrial
    • Infrastructure
    • Media
    • Mining
    • Oil & Gas
    • Retail
    • Technology
    • Telecommunication
  • Market
    • Commodities
    • Currency
    • IPO
    • Hybrid Security
    • Market Updates
    • Upcoming Dividends
    • Dividend Yield
    • Director’s Interests
  • Editorial
  • Videos
  • Investor Education
  • Life & Luxury
    • Food & Drinks
    • Travel
    • Gadgets
    • Health & Wellness
    • Lifestyle
    • Fitness
  • Forum
  • Need Recommendations?
Search
Sunday, December 15, 2019
  • Home
  • About
  • Meet The Team
  • Investment Reports
  • Contact Us
  • Advertise With us
Kalkine Media
  • NEWS
    • Australian Shares
    • US Shares
    • World Economy
  • ASX Companies
    • Consumer
    • Energy
    • Financial
    • Food & Beverages
    • Healthcare
    • Industrial
    • Infrastructure
    • Media
    • Mining
    • Oil & Gas
    • Retail
    • Technology
    • Telecommunication
  • Market
    • Commodities
    • Currency
    • IPO
    • Hybrid Security
    • Market Updates
    • Upcoming Dividends
    • Dividend Yield
    • Director’s Interests
  • Editorial
  • Videos
  • Investor Education
  • Life & Luxury
    • Food & Drinks
    • Travel
    • Gadgets
    • Health & Wellness
    • Lifestyle
    • Fitness
  • Forum
  • Need Recommendations?

Phylogica Ltd. (ASX:PYC)
Share Price and News


Company Profile:

Phylogica Limited (ASX: PYC) is into the business of biopharmaceuticals. The company utilises proprietary drug discovery technologies to develop novel peptide therapies. The company is headed by Mr Rohan Hockings, who is also the CEO of the company. The registered office of the company is located in Mt. Pleasant, Western Australia, Australia.



Code : ASX:PYC Healthcare Company


Latest News

Team KalkineBlog
Market Crash: Boon or Bane for Investment Opportunities
Team KalkineFlash News
Sigma Healthcare updated FY20 EBITDA Guidance
Team KalkineFlash News
Mt Marion finalised the sale price for 6% Spodumene Concentrate
Team KalkineFlash News
Lynas to Submit Compliant US Department of Defence Tender
Team KalkineFlash News
GDI Property Provide Details of the Dividend Distribution

Phylogica Ltd. (ASX:PYC) Latest News


NEWS
How To Find Good Small And Mid-Cap Stocks To Invest In: A look At PYC, ADT, SPQ, EN1
Flash News
PYC Therapeutics Successfully Completed Evaluation of CPP
Blog
Three ASX Players Catering to Health Sector- CLI, PYC, BDA
NEWS
Phylogica Limited Announces A Collaboration Agreement With Ramot
NEWS
Phylogica Limited Releases its first Competitive read-out concerning Peptide Vaccine
Healthcare Companies
Phylogica Limited (ASX: PYC)
×

NEED STOCK RECOMMENDATIONS FROM EXPERTS? GET A CALL BACK NOW


By clicking on Submit, you agree to our Privacy Policy. Your information is not shared with third parties.

We provide you with the latest news and videos straight from the stock market. Reach us at: Suite 202, 234 George Street, Sydney NSW 2000

Contact us: info@kalkinemedia.com

  • News
  • Blog
  • Forum
  • Video
  • Editorial
  • Currency
  • Commodity
  • Market Updates
  • Hybrid Security
  • Upcoming Dividend
  • Investor Education
  • CEO Interview
  • Australian Shares
  • Mining
  • Consumer
  • Financial
  • Healthcare
  • Industrial
  • Media
  • Oil & Gas
  • Technology
  • Infrastructure
  • Food & Beverages
  • Telecommunication
  • IPO
  • Retail
  • Cannabis
  • Biotech
  • Metals
  • Resources
  • Dividend Yield
  • US Shares
  • ASX Companies
  • Sponsored
  • Meet The Team
  • Investment Reports

© Kalkine Media Pty Ltd 2019 All Rights reserved
 ACN: 629 651 672     ABN: 84 629 651 672

  • Media
  • Privacy Policy
  • Web Content Policy
  • Terms and Conditions
  • Disclaimer
  • Contact Us

© Kalkine Media Pty Ltd 2018 All Rights reserved
 ACN: 629 651 672     ABN: 84 629 651 672

Edit with Live CSS
Save
Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.